Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section


Nov-Dec 2004 edition

  • Guidelines for Antiretroviral Agents in Pediatrics - Adverse Events
  • Guidelines for Antiretroviral Agents in Pediatrics - Pain and Nutrition
  • Depo-Provera Contraceptive Injection - New Warnings from the FDA Regarding Bone Loss
  • Medication Safety: Metal Content of Transdermal Patches Gemini Update - Goal of Therapy
  • P&T Formulary Actions

Sep-Oct 2004 edition

  • COX-2 Inhibitors - Cardiovascular and Gastrointestinal Safety
  • Oral Erythromycin and Risk of Sudden Cardiac Death
  • Common Drug Interactions between Herbal and Prescription Medications
  • High-Alert Medications - Patient Safety

Jul-Aug 2004 edition

  • Diphenhydramine and Dextromethorphan for Pediatric Cough 
  • Updated Guidelines for ST-Elevation Myocardial Infarction
  • Updated HIV/AIDS Treatment Guidelines from the International AIDS Society - USA Panel
  • P&T Committee Formulary Action / May - August 2004

Mar-Apr 2004 edition

  • Patient Safety Initiative: New “Do Not Use” Abbreviation List
  • Health Advisories: Antidepressants and Atypical Antipsychotics
  • Management of Otitis Media
  • Post Menopausal Use of Estrogen and Progestin
  • New on the Horizon: Rimonibant
  • P&T Committee Formulary Action - Feb/Mar/Apr 2004

Jan-Feb 2004 edition

  • 5 Mg versus 10 Mg Warfarin Nomograms
  • Updated Guidelines for Hypertension – JNC 7
  • Drug-Eluting Stents and the Potential Risk Of Thrombosis
  • Medication Safety - Drugs and QT Prolongation Methylprednisolone IV in Spinal Cord Injury
  • P&T Committee Formulary Action - January 2004